Back to Newsroom
Back to Newsroom

EVITRADE Announces Closing of TREE Chest Safety Corp. Acquisition

Thursday, 08 November 2018 12:42 AM

EGF Theramed Health Corp.

VANCOUVER, BC / ACCESSWIRE / November 8, 2018 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company" or "Evitrade") is pleased to announce that, further to its press release dated August 23, 2018, that it has agreed to close the acquisition of Tree Chest Safety Corp. (TREE) effective November 7th, 2018. TREE manufactures and markets lockable air tight storage compartments specifically designed to store and preserve products while preventing children from accessing the contents.

"As previously quoted, we believe this technology furthers the development of offerings for the company's end to end healthcare systems" said C.K. Cheung, “and the Company is excited to adding this technology and diversity to the Company's offerings”.

Pursuant to the agreement Evitrade was to acquire all of the issued and outstanding common shares of TREE for an aggregate of up to $2,500,000 in cash and shares and the company is to issue 6,666,667 common shares of Evitrade at a deemed price of $.30. The result of the Transaction is TREE has become a wholly-owned subsidiary of Evitrade.

Management of Evitrade believes the acquisition will further continue to enhance Evitrade's business and commercialization strategies.

For more information, please contact:

C.K. Cheung, CEO & Director
Or Ron Ozols, Director
EVITRADE Health Systems Corporation
Email [email protected]
Website http://www.evahealthsystems.com
CSE Micro-site: http://thecse.com/en/listings/technology/evitrade-health-systems-corp
US OTC Markets (OTCQB): http://www.otcmarkets.com/stock/EVAHF/news

About EVITRADE Health (CSE: EVA, OTCQB: EVAHF)

EVITRADE Health Systems Corp., is a Technology company specializing in the Life Sciences sector looking to deliver effective health solutions with a higher degree of predictability and consistency. The Company is focused in four main areas, Autonomous Medical Care, Molecular Biology, Nutraceutical Solutions and Genetic Selection. Through its Focus on Autonomous Medical Care, the Company offers a physiologically interactive computing platform that integrates medical devices and artificial intelligence applications into a fully automated, personal health management system for various chronic conditions.

Forward Looking Statements; Disclaimers

This news release contains forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward looking statements. The Company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators and on the OTC Markets website which are posted on www.sedar.com, http://thecse.com/en/listings/technology/evitrade-health-systems-corp, and https://www.otcmarkets.com/stock/EVAHF/news, respectively. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), or any other regulatory authority accepts responsibility for the adequacy or accuracy of this release. The Company does not undertake to update this news release unless required by applicable law.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

SOURCE: EVITRADE Health Systems Corp.

Topic:
Company Update
Back to newsroom
Back to Newsroom

Contact Us Today


If you have questions or want to learn more about our products, our team’s here to help!

Share by: